The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica.


Journal

Reumatismo
ISSN: 0048-7449
Titre abrégé: Reumatismo
Pays: Italy
ID NLM: 0401302

Informations de publication

Date de publication:
10 Apr 2020
Historique:
received: 13 12 2019
accepted: 21 03 2020
entrez: 16 4 2020
pubmed: 16 4 2020
medline: 24 3 2021
Statut: epublish

Résumé

to provide evidence-based up-to-date recommendations for the management of patients with a definite diagnosis of polymyalgia rheumatica (PMR). A systematic literature review was performed to find the existing clinical practice guidelines (CPGs) on PMR and the framework of the Guidelines International Network Adaptation Working Group was used to appraise (AGREE II), synthesize, and customize the recommendations according to the needs of the Italian healthcare context. Rheumatologists on behalf of the Italian Society of Rheumatology (SIR) and from the SIR Epidemiology Unit joined the working group and identified the key health questions on PMR to guide the systematic literature review. Physicians, including general practitioners and specialists, and health professionals who manage PMR in the clinical practice were the target audience. The final recommendations were rated externally by a multi-disciplinary and multi-professional group of stakeholders. From the systematic search in databases (Medline, Embase) and grey literature, 3 CPGs were identified and appraised by two independent raters. Combining the statements and the evidence from these CPGs, 9 recommendations were developed by endorsement or adaptation in response to the initial key health questions. The quality of evidence was graded and the working group discussed the final recommendations in view of their implementation in the Italian healthcare context. In absence of national guidelines so far, these recommendations are the first to provide guidance for the management of patients with a diagnosis of PMR in Italy and they are expected to ensure the best evidence-based clinical practice for this disease.

Identifiants

pubmed: 32292016
doi: 10.4081/reumatismo.2020.1268
doi:

Substances chimiques

Anti-Inflammatory Agents, Non-Steroidal 0
Glucocorticoids 0
Immunosuppressive Agents 0
Methotrexate YL5FZ2Y5U1

Types de publication

Journal Article Practice Guideline Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-15

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

N Ughi (N)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Division of Rheumatology, ASST Grande Ospedale Metropolitano Niguarda, Milano. n.ughi@reumatologia.it.

G D Sebastiani (GD)

Rheumatology Unit, Azienda Ospedaliera San Camillo-Forlanini, Roma. giandoreum@libero.it.

R Gerli (R)

Rheumatology Unit, Department of Medicine, University of Perugia, Perugia. roberto.gerli@unipg.it.

C Salvarani (C)

Rheumatology Unit, Department of Internal Medicine, Azienda Ospedaliera ASMN IRCCS, Reggio Emilia. Carlo.Salvarani@ausl.re.it.

S Parisi (S)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Rheumatology Unit, Azienda Ospedaliera Città della Salute e della Scienza di Torino, Torino. simone.parisi@hotmail.it.

A Ariani (A)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Department of Medicine, Internal Medicine and Rheumatology Unit, Azienda Ospedaliero-universitaria di Parma, Parma. atendoro@gmail.com.

I Prevete (I)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Rheumatology Unit, Azienda Ospedaliera San Camillo-Forlanini, Roma. immaprevete@virgilio.it.

M Manara (M)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Department of Rheumatology, ASST Gaetano Pini-CTO, Milano. maria.manara@gmail.com.

F Rumi (F)

Epidemiology Unit, Italian Society for Rheumatology, Milan. f.rumi@reumatologia.it.

C A Sciré (CA)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Department of Medical Sciences, Rheumatology Section, University of Ferrara, Azienda Ospedaliero-Universitaria Sant'Anna di Cona, Ferrara. c.scire@reumatologia.it.

A Bortoluzzi (A)

Epidemiology Unit, Italian Society for Rheumatology, Milan, Italy; Department of Medical Sciences, Rheumatology Section, University of Ferrara, Azienda Ospedaliero-Universitaria Sant'Anna di Cona, Ferrara. alessandra.bortoluzzi@unife.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH